Implantable Defibrillators and Combined ICD-Resynchronization Therapy in Patients with Heart Failure

Resynchronization and Defibrillation for Heart Failure: A Practical Approach

Volumn , Issue , 2008, Pages 177-208

  Wang, Paul J ^a   Hayes, David L ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Eart patients; Heart failure; Implantable cardioverter defibrillators; Resynchronization therapy; Ventricular arrhythmias

Indexed keywords

EID: 9144231521     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470757727.ch7     Document Type: Chapter

References (30)

1. Swygman C, Wang PJ, Link MS, Homoud MK, Estes NA III. Advances in implantable cardioverter defibrillators. Curr Opin Cardiol 2002;17:24-8.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest:the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
4. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al., for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease [published erratum appears in N Engl J Med 2000;342:1300]. N Engl J Med 1999;341:1882-90.
7. Bigger JT Jr, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-75.
8. Moss AJ, Zareba W, Hall WJ, Klein H,Wilber DJ, Cannom DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
9. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-8.
10. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al., for the AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003;41:1707-12.
11. Klein H, Auricchio A, Reek S, Geller C. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83 (Suppl 5B):91D-7D.
12. Kadish A, Quigg R, Schaechter A, Anderson KP, Estes M, Levine J. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 2000;23:338-43.
13. Hohnloser SH, Connolly SJ, Kuck KH, Dorian P, Fain E, Hampton JR, et al., for the DINAMIT Investigators. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT):study protocol. Am Heart J 2000;140:735-9.
14. Seidl K, Hoffmann E, Brüggemann T, Brachmann J, Andresen D. IRIS: Immediate Risk Stratification Improves Survival. Europace 2000;1:D293.
15. Bristow MR, Feldman AM, Saxon LA, for the COMPANION Steering Committee and COMPANION Clinical Investigators. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. J Card Fail 2000;6:276-85.
16. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002;40:1703-19.
17. Winters SL, Packer DL, Marchlinski FE, Lazzara R, Cannom DS, Breithardt GE, et al. Consensus statement on indications, guidelines for use, and recommendations for follow- up of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2001;24:262-9.
18. Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NA III, Wang PJ. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997;29:370-5.
19. Cohen TJ, Klein J. Cardiac resynchronization therapy for treatment of chronic heart failure. J Invasive Cardiol 2002;14:48-53.
20. Bocchiardo M, Achtelik M, Gaita F, Trappe HJ, Lozano I, Higgins S, et al., for the VENTAK CHF/CONTAK CD Investigators. Efficacy of biventricular sensing and treatment of ventricular arrhythmias. Pacing Clin Electrophysiol 2000;23:1989-91.
21. Lozano I, Bocchiardo M, Achtelik M, Gaita F, Trappe HJ, Daoud E, et al., for the VENTAK CHF/CONTAK CD Investigators Study Group. Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin Electrophysiol 2000;23:1711-2.
22. Kühlkamp V, for the InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002;39:790-7.
23. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al., for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-94.
24. Barold HS. Preliminary clinical review of Guidant's Contak CD/Contak renewal heart failure devices and EasyTrak Lead System PMA. Available at: http://www.fda.gov/cdrh/panel/briefing/071001-tl-review.pdf. Accessed November 28, 2003.
25. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-40.
26. Garrigue S, Barold SS, Hocini M, Jais P, Haissaguerre M, Clementy J. Treatment of drug refractory ventricular tachycardia by biventricular pacing. Pacing Clin Electrophysiol 2000;23:1700-2.
27. Higgins SL,Yong P, Sheck D, McDaniel M, Bollinger F,Vadecha M, et al., for the Ventak CHF Investigators. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:824-7.
28. Martinelli Filho M, Pedrosa A, Costa R, Nishioka S, Siqueira S, Crevleari E, et al. Biventricular pacing reduces frequency and complexity of ventricular arrhythmia in patients with congestive heart failure. Europace 2000:1 Suppl D:D227.
29. Walker S, Levy TM, Rex S, Paul VE. Biventricular pacing decreases ventricular arrhythmia [abstract]. Circulation 2000;102 Suppl 2:II-692-3.
30. Hayes DL, Naccarelli GV, Furman S, Parsonnet V, Reynolds D, Goldschlager N, et al. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol 2003;26:1556-62.